Repligen Corporation (RGEN)
NASDAQ: RGEN · Real-Time Price · USD
132.60
+1.39 (1.06%)
Apr 20, 2026, 11:45 AM EDT - Market open
Repligen Employees
Repligen had 2,000 employees as of December 31, 2025. The number of employees increased by 222 or 12.49% compared to the previous year.
Employees
2,000
Change (1Y)
222
Growth (1Y)
12.49%
Revenue / Employee
$369,128
Profits / Employee
$24,447
Market Cap
7.48B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 2,000 | 222 | 12.49% |
| Dec 31, 2024 | 1,778 | -5 | -0.28% |
| Dec 31, 2023 | 1,783 | -242 | -11.95% |
| Dec 31, 2022 | 2,025 | 173 | 9.34% |
| Dec 31, 2021 | 1,852 | 724 | 64.18% |
| Dec 31, 2020 | 1,128 | 367 | 48.23% |
| Dec 31, 2019 | 761 | 213 | 38.87% |
| Dec 31, 2018 | 548 | 72 | 15.13% |
| Dec 31, 2017 | 476 | 240 | 101.69% |
| Dec 31, 2016 | 236 | 68 | 40.48% |
| Dec 31, 2015 | 168 | 32 | 23.53% |
| Dec 31, 2014 | 136 | 20 | 17.24% |
| Dec 31, 2013 | 116 | -4 | -3.33% |
| Dec 31, 2012 | 120 | -17 | -12.41% |
| Dec 31, 2011 | 137 | 69 | 101.47% |
| May 6, 2010 | 68 | -1 | -1.45% |
| May 31, 2009 | 69 | 13 | 23.21% |
| May 27, 2008 | 56 | 11 | 24.44% |
| Jun 30, 2007 | 45 | 2 | 4.65% |
| Jun 6, 2006 | 43 | 6 | 16.22% |
| Jun 7, 2005 | 37 | -3 | -7.50% |
| Jun 7, 2004 | 40 | -4 | -9.09% |
| May 15, 2003 | 44 | 5 | 12.82% |
| May 15, 2002 | 39 | -1 | -2.50% |
| May 15, 2001 | 40 | 13 | 48.15% |
| May 15, 2000 | 27 | 3 | 12.50% |
| May 15, 1999 | 24 | 0 | - |
| May 29, 1998 | 24 | 4 | 20.00% |
| May 15, 1997 | 20 | 5 | 33.33% |
| Jun 14, 1996 | 15 | -89 | -85.58% |
| Mar 31, 1995 | 104 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Baxter International | 37,500 |
| Solventum | 20,584 |
| Align Technology | 20,290 |
| Teleflex | 15,500 |
| The Cooper Companies | 15,000 |
| AptarGroup | 14,000 |
| Avantor | 13,500 |
| Bausch + Lomb | 13,000 |
RGEN News
- 3 days ago - Repligen Opens European Training & Innovation Center in Breda, Expanding Global Customer Support Network - GlobeNewsWire
- 7 weeks ago - Repligen Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance - GlobeNewsWire
- 2 months ago - Repligen to Report Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 3 months ago - Repligen Executive Chair Tony Hunt to Retire; Dr. Martin D. Madaus Elected Chair - GlobeNewsWire
- 4 months ago - Repligen Corporation to Present at J.P. Morgan 2026 Healthcare Conference - GlobeNewsWire
- 4 months ago - Repligen Introduces Next-Generation Chromatography Resins to Advance New Modality Workflows - GlobeNewsWire
- 5 months ago - Repligen Corporation to Present at Evercore Healthcare Conference - GlobeNewsWire
- 6 months ago - Repligen Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance - GlobeNewsWire